Regional differences in thyroid cancer presentation and survival: A seer study

Jessica Rose, Betsy Wertheim, Marlon A Guerrero

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: The incidence of thyroid cancer has been steadily increasing. Several studies have identified gender and racial/ethnic differences in the incidence and prognosis of thyroid cancer. In this study, we sought to determine if the stage of presentation and survival rate of patients with thyroid cancer in the United States is affected by geographic region.Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we identified 100,404 patients diagnosed with thyroid cancer from 1973 through 2009. We assessed historical stage of diagnosis and cancer-free survival rate according to geographic region. To compare stages of diagnosis, we used multinomial logistic regression. To compare survival rates, we used Cox proportional hazards regression. Models were adjusted for age, year of diagnosis, cancer type, registry site, race/ethnicity, and stage.Results: Of 100,404 patients, 52,902 (52.7%) were from the West, 17,915 (17.8%) from the East, 15,302 (15.2%) from the South, and 14,285 (14.2%) from the Midwest. Overall, most patients presented with localized disease. Those from the West had a higher risk of presenting with regional and distant metastases. When we double-stratified by cancer subtype and racial group, we found no significant associations between geographic region and cancer-free survival rate.Conclusion: The presentation stage and survival rate of patients with thyroid cancer differs by geographic region, but not within separate racial/ethnic groups.

Original languageEnglish (US)
Pages (from-to)998-1006
Number of pages9
JournalEndocrine Practice
Volume19
Issue number6
DOIs
StatePublished - Nov 1 2013

Fingerprint

Thyroid Neoplasms
Survival Rate
Survival
Neoplasms
Incidence
Ethnic Groups
Registries
Epidemiology
Logistic Models
Databases
Neoplasm Metastasis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Regional differences in thyroid cancer presentation and survival : A seer study. / Rose, Jessica; Wertheim, Betsy; Guerrero, Marlon A.

In: Endocrine Practice, Vol. 19, No. 6, 01.11.2013, p. 998-1006.

Research output: Contribution to journalArticle

Rose, Jessica ; Wertheim, Betsy ; Guerrero, Marlon A. / Regional differences in thyroid cancer presentation and survival : A seer study. In: Endocrine Practice. 2013 ; Vol. 19, No. 6. pp. 998-1006.
@article{f87139af91bd40bd8ca0d67cb26ab6d2,
title = "Regional differences in thyroid cancer presentation and survival: A seer study",
abstract = "Objective: The incidence of thyroid cancer has been steadily increasing. Several studies have identified gender and racial/ethnic differences in the incidence and prognosis of thyroid cancer. In this study, we sought to determine if the stage of presentation and survival rate of patients with thyroid cancer in the United States is affected by geographic region.Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we identified 100,404 patients diagnosed with thyroid cancer from 1973 through 2009. We assessed historical stage of diagnosis and cancer-free survival rate according to geographic region. To compare stages of diagnosis, we used multinomial logistic regression. To compare survival rates, we used Cox proportional hazards regression. Models were adjusted for age, year of diagnosis, cancer type, registry site, race/ethnicity, and stage.Results: Of 100,404 patients, 52,902 (52.7{\%}) were from the West, 17,915 (17.8{\%}) from the East, 15,302 (15.2{\%}) from the South, and 14,285 (14.2{\%}) from the Midwest. Overall, most patients presented with localized disease. Those from the West had a higher risk of presenting with regional and distant metastases. When we double-stratified by cancer subtype and racial group, we found no significant associations between geographic region and cancer-free survival rate.Conclusion: The presentation stage and survival rate of patients with thyroid cancer differs by geographic region, but not within separate racial/ethnic groups.",
author = "Jessica Rose and Betsy Wertheim and Guerrero, {Marlon A}",
year = "2013",
month = "11",
day = "1",
doi = "10.4158/EP13046.OR",
language = "English (US)",
volume = "19",
pages = "998--1006",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "6",

}

TY - JOUR

T1 - Regional differences in thyroid cancer presentation and survival

T2 - A seer study

AU - Rose, Jessica

AU - Wertheim, Betsy

AU - Guerrero, Marlon A

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Objective: The incidence of thyroid cancer has been steadily increasing. Several studies have identified gender and racial/ethnic differences in the incidence and prognosis of thyroid cancer. In this study, we sought to determine if the stage of presentation and survival rate of patients with thyroid cancer in the United States is affected by geographic region.Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we identified 100,404 patients diagnosed with thyroid cancer from 1973 through 2009. We assessed historical stage of diagnosis and cancer-free survival rate according to geographic region. To compare stages of diagnosis, we used multinomial logistic regression. To compare survival rates, we used Cox proportional hazards regression. Models were adjusted for age, year of diagnosis, cancer type, registry site, race/ethnicity, and stage.Results: Of 100,404 patients, 52,902 (52.7%) were from the West, 17,915 (17.8%) from the East, 15,302 (15.2%) from the South, and 14,285 (14.2%) from the Midwest. Overall, most patients presented with localized disease. Those from the West had a higher risk of presenting with regional and distant metastases. When we double-stratified by cancer subtype and racial group, we found no significant associations between geographic region and cancer-free survival rate.Conclusion: The presentation stage and survival rate of patients with thyroid cancer differs by geographic region, but not within separate racial/ethnic groups.

AB - Objective: The incidence of thyroid cancer has been steadily increasing. Several studies have identified gender and racial/ethnic differences in the incidence and prognosis of thyroid cancer. In this study, we sought to determine if the stage of presentation and survival rate of patients with thyroid cancer in the United States is affected by geographic region.Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we identified 100,404 patients diagnosed with thyroid cancer from 1973 through 2009. We assessed historical stage of diagnosis and cancer-free survival rate according to geographic region. To compare stages of diagnosis, we used multinomial logistic regression. To compare survival rates, we used Cox proportional hazards regression. Models were adjusted for age, year of diagnosis, cancer type, registry site, race/ethnicity, and stage.Results: Of 100,404 patients, 52,902 (52.7%) were from the West, 17,915 (17.8%) from the East, 15,302 (15.2%) from the South, and 14,285 (14.2%) from the Midwest. Overall, most patients presented with localized disease. Those from the West had a higher risk of presenting with regional and distant metastases. When we double-stratified by cancer subtype and racial group, we found no significant associations between geographic region and cancer-free survival rate.Conclusion: The presentation stage and survival rate of patients with thyroid cancer differs by geographic region, but not within separate racial/ethnic groups.

UR - http://www.scopus.com/inward/record.url?scp=84888876090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888876090&partnerID=8YFLogxK

U2 - 10.4158/EP13046.OR

DO - 10.4158/EP13046.OR

M3 - Article

C2 - 24013978

AN - SCOPUS:84888876090

VL - 19

SP - 998

EP - 1006

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 6

ER -